Mylan NV (MYL) - Comprehensive Stock Analysis & Investment Research
Deep dive into Mylan NV's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Understanding Company Overview
What this section covers: Essential business information about Mylan NV, including sector classification, industry positioning, and organizational structure.
How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.
For Mylan NV: Mylan NV operates in the Health Technology sector, establishing it as a mid-cap growth opportunity.
Mylan NV (Stock Symbol: MYL) is a leading company in the Health Technology sector , specifically operating within the Pharmaceuticals: Generic industry.
The organization employs approximately 35000 professionals worldwide and operates under the strategic leadership of CEO Heather M. Bresch.
The company has established itself as a growing mid-cap opportunity with strong fundamentals.
Understanding Financial Performance
What these metrics mean: Key financial indicators showing Mylan NV's revenue scale, profitability, market value, and shareholder returns.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For Mylan NV: With $11514M in annual revenue and 2.3% net margin, the company demonstrates developing profitability.
Annual Revenue: $11514 million generating a 2.3% net profit margin .
Market Capitalization: $8215 million - Classified as a mid-cap growth stock with balanced risk-reward profile.
Return on Equity (ROE): 2.2% - Below-average shareholder return efficiency, indicating areas for operational improvement.
Understanding AI Stock Predictions
What these predictions mean: AI-powered forecasts for Mylan NV stock using machine learning algorithms trained on historical market data and technical indicators.
How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.
For Mylan NV: Unlock premium access to view detailed AI predictions and price targets.
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Mylan NV stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Understanding Market Position
What this analysis covers: Mylan NV's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.
How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.
For Mylan NV: Strong free cash flow generation demonstrates exceptional operational efficiency.
Mylan NV strategically competes in the highly dynamic Pharmaceuticals: Generic marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .
The company demonstrates robust operational efficiency through strong free cash flow generation of $1539 million annually, complemented by impressive -23.0% year-over-year cash flow growth.
The company maintains a healthy 36.3% gross margin, indicating strong pricing power and operational efficiency.